CareDx, Inc. (CDNA) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-06

Key Insights

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, sold 2,688 shares on May 5, 2026 at a weighted average price of $20.68, representing a planned divestment under a Rule 10b5-1 trading plan adopted in September 2025.
The insider's remaining beneficial ownership of 113,924 shares indicates a substantial retained stake, suggesting continued confidence despite the planned stock sale.
The use of a pre-established 10b5-1 trading plan demonstrates this was a scheduled, systematic sale rather than a sudden liquidation, reducing concerns about loss of confidence in the company's near-term prospects.
The sale amount (~$55,500) is relatively modest compared to the insider's total holdings, suggesting this is routine portfolio rebalancing rather than a significant exit by a key officer.

Want the newest filings?

This analysis covers the filing from 2026-05-06. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-05-04

Secretary and General Counsel Jeffrey Adam Novack disposed of 2,873 shares on 05/01/2026 at $21.50 per share through a tax withholding arrangement related to restricted stock unit vesting, indicating routine equity compensation execution rather than a discretionary sale.
Following the transaction, Novack maintains direct beneficial ownership of 116,612 shares of CDNA common stock, demonstrating continued significant insider holdings and alignment with shareholder interests despite the modest disposition.
The transaction was executed via Rule 10b5-1(c) compliant mechanism (tax withholding), which is a standard, pre-planned arrangement for equity-based compensation and carries no negative inference regarding insider confidence in the company.

Filed: 2026-04-22

CFO & COO Kennedy Keith acquired 24,134 RSUs (restricted stock units) on April 20, 2026, with a $0 grant price, indicating a compensation award rather than market purchase.
The RSU vesting schedule spans 3 years with one-third vesting on April 6, 2027, followed by eight equal quarterly installments, demonstrating a long-term retention incentive aligned with executive continuity.
Following this transaction, Keith's total beneficial ownership reached 221,548 shares, reflecting significant personal stake in the company's performance as a senior executive.
The filing was executed by attorney-in-fact Jeffrey Adam Novack on April 22, 2026, two days after the transaction date, indicating standard administrative processing of executive compensation.

Filed: 2026-04-16

John Walter Hanna Jr., the President and CEO of CareDx, Inc., disposed of 62,049 shares of common stock on April 15, 2026, likely to satisfy tax withholding obligations related to the vesting of restricted stock units.
Following the transaction, Hanna still holds a significant stake of 686,757 shares, indicating his continued commitment to the company.
The timing of the transaction and the relatively small amount of shares disposed compared to Hanna's total holdings suggest this is a routine transaction and not indicative of any major concerns or changes in his outlook for the company.

Filed: 2026-04-07

The reporting person, Jeffrey Adam Novack, the Secretary and General Counsel of CareDx, Inc., disposed of 1,892 shares of the company's common stock through a stock withholding transaction to satisfy certain tax obligations.
This transaction reduced Novack's direct beneficial ownership of CareDx shares to 119,485, indicating he continues to maintain a sizable stake in the company.
The timing and relatively small size of this transaction suggest it was a routine tax-related event and likely not indicative of any broader concerns or changes in Novack's view of the company.

Filed: 2026-04-03

Insider Michael Goldberg acquired 1,981 shares of CareDx, Inc. (CDNA) common stock on April 2, 2026, increasing his direct beneficial ownership to 185,942 shares.
The share acquisition was an automatic quarterly grant to Goldberg as non-employee director compensation, indicating his continued involvement and commitment to the company.
Insider ownership can be a positive signal for investors, as it aligns the interests of management with shareholders.

Filed: 2026-04-03

John Walter Hanna, Jr., the President and CEO of CareDx, Inc. (CDNA), disposed of 35,037 shares of the company's common stock through a share withholding transaction to satisfy certain tax obligations.
Hanna's current beneficial ownership of CDNA shares stands at 748,806 shares, indicating he maintains a significant stake in the company.
The share disposition occurred on April 1, 2026, suggesting Hanna's continued commitment to the company despite the transaction.

Filed: 2026-04-03

The reporting person, Keith Kennedy, who is the CFO and COO of CareDx, Inc., disposed of 11,725 shares of common stock on April 1, 2026, likely to satisfy tax withholding obligations related to the vesting of restricted stock units.
Following this transaction, the reporting person still beneficially owns 197,414 shares of CareDx's common stock, indicating they continue to hold a significant equity position in the company.
The transaction appears to be routine and not indicative of any major changes in the reporting person's investment strategy or sentiment towards the company.

Filed: 2026-04-03

Jessica Meng, the Chief Commercial Officer of CareDx, Inc., has disposed of 7,386 shares of the company's common stock in a transaction on 2026-04-01.
The transaction was carried out to satisfy certain tax withholding obligations in connection with the vesting of restricted stock units, indicating a routine insider activity.
Following the transaction, Meng's direct beneficial ownership of CareDx's common stock remains at 169,392 shares.

Filed: 2026-04-03

The reporting person, Jeffrey Adam Novack, is the Secretary and General Counsel of CareDx, Inc. (CDNA), indicating he is an insider with relevant information about the company.
Novack disposed of 3,987 shares of CDNA common stock on April 1, 2026, likely to satisfy tax withholding obligations related to the vesting of restricted stock units.
After the reported transaction, Novack still holds 121,377 shares of CDNA common stock directly, suggesting he maintains a significant equity stake in the company.

Filed: 2026-04-01

The reporting person, Michael Goldberg, executed a series of stock option exercises on March 31, 2026, acquiring a total of 26,500 shares of CareDx, Inc. (CDNA) common stock.
The options exercised had strike prices ranging from $1.22 to $5.02, indicating Goldberg is taking advantage of the current stock price to exercise in-the-money options.
Following the reported transactions, Goldberg's direct beneficial ownership of CareDx common stock has increased to 183,961 shares, suggesting increased confidence in the company's long-term prospects.

Filed: 2026-02-04

Insider Jessica Meng, the Chief Commercial Officer, acquired 60,000 restricted stock units (RSUs) and 11,579 performance restricted stock units (PRSUs), indicating her confidence in the company's future.
Meng sold 4,430 shares to cover tax withholding obligations, which is a common practice and does not necessarily signal a lack of confidence.
The vesting of the RSUs and PRSUs is tied to Meng's continued employment and the achievement of certain performance criteria, aligning her interests with those of shareholders.

Filed: 2026-02-04

Nathan Smith, the Chief Financial Officer of CareDx, Inc. (CDNA), acquired 33,000 shares of the company's common stock through restricted stock units (RSUs) and an additional 7,875 shares through performance-based RSUs, indicating his confidence in the company's future performance.
Smith also sold 3,859 shares to cover tax withholding obligations, suggesting he is holding on to a significant portion of his equity stake in the company.
The vesting schedule of the RSUs, with one-third vesting on April 6, 2027 and the remaining two-thirds vesting over the subsequent eight quarters, aligns Smith's interests with those of long-term shareholders.

Filed: 2026-02-04

Jeffrey Adam Novack, the Secretary and General Counsel of CareDx, Inc. (CDNA), acquired 33,000 shares of the company's common stock through a restricted stock unit (RSU) award, as well as an additional 4,342 shares through a performance restricted stock unit (PRSU) award.
Novack disposed of 2,492 shares to cover tax withholding obligations related to the vesting of PRSUs, and an additional 2,970 shares to cover tax withholding obligations related to the vesting of RSUs.
Novack also sold 4,441 shares of the company's common stock on the open market, likely for personal reasons, in a transaction that was conducted pursuant to a Rule 10b5-1 trading plan.

Filed: 2026-02-04

The President and CEO of CareDx, Inc. (CDNA) acquired 162,500 restricted stock units (RSUs) and 37,632 performance-based RSUs, indicating strong executive confidence in the company's future.
The reporting person disposed of 13,694 shares to cover tax withholding obligations, suggesting a commitment to retaining a significant equity stake in the company.
The vesting schedule for the RSUs, with one-third vesting in April 2027 and the remainder over the following eight quarters, aligns the executive's interests with long-term shareholder value creation.

Other reports for CareDx, Inc.

Quarterly Report Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.